Victory Capital Management
BIOR

Victory Capital Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Victory Capital Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-75
Closed -$2.48K – 2750
2022
Q4 		$2.48K Hold
75
– – ﹤0.01% 2580
2022
Q3 		$9K Sell
75
-20
-21% -$3.6K ﹤0.01% 2666
2022
Q2 		$17K Sell
95
-1
-1% -$211 ﹤0.01% 2632
2022
Q1 		$20K Buy
96
+9
+10% +$3.42K ﹤0.01% 2643
2021
Q4 		$45K Buy
87
+30
+53% +$21.5K ﹤0.01% 2652
2021
Q3 		$22K Buy
+57
New +$24.4K ﹤0.01% 2727

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Victory Capital Management's BIOR Position: Q1 2023 in Review

Victory Capital Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2023, closing a stake of 75 shares — an estimated $2.48K sold.

Victory Capital Management first reported a position in BIOR in Q3 2021 and held it in 6 quarters. The position peaked at $45K in Q4 2021. 30 funds tracked by Wall St. Rank hold BIOR as of Q1 2023.

  • Victory Capital Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Victory Capital Management sold 75 Biora Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $2.48K.
  • Victory Capital Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Victory Capital Management's Biora Therapeutics, Inc. Common Stock position peaked at $45K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Victory Capital Management's 13F filing for Q1 2023, filed 2 May 2023.